Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
Background Primary percutaneous coronary intervention (PCI) has significantly improved outcomes for ST-segment elevation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback